- CEO
- De Lai Li
- Full Time Employees
- 737
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Shantou China
- IPO Date
- Jan 22, 2025
- Business
- Shantou Institute of Ultrasonic Instruments Co. Ltd. is a China-based developer and manufacturer of medical imaging equipment and industrial non-destructive testing instruments. Founded in 1982 and headquartered in Shantou, Guangdong Province, China, the company researches, engineers, and markets ultrasonic diagnostic and inspection solutions for clinical healthcare, veterinary medicine, and industrial inspection applications across domestic and international markets.
The company operates primarily through two business divisions: Medical Imaging Systems and Non-Destructive Testing (NDT) Equipment. Its medical product portfolio encompasses color Doppler ultrasound diagnostic systems marketed under the Apogee series; black-and-white ultrasonic diagnostic equipment; dedicated veterinary ultrasound imaging devices; and portable digital radiography (DR) X-ray systems, including the SR series, utilized in emergency medicine, radiology, and veterinary care. Its industrial NDT portfolio comprises phased-array ultrasonic flaw detectors, including the SyncScan series; conventional and portable ultrasonic flaw detectors under the Smartor series; precision ultrasonic thickness gauges; automated scanning and rail flaw detection systems; electromagnetic acoustic testing instruments; and an extensive catalog of ultrasonic transducers, phased array probes, calibration blocks, scanning crawlers, and inspection accessories. The company serves public and private hospitals, diagnostic centers, and veterinary clinics, as well as industrial clients across the aerospace, nuclear power, railway transportation, petrochemical, metallurgy, shipbuilding, and infrastructure construction sectors.
In recent developments, Shantou Institute of Ultrasonic Instruments completed its initial public offering and listed its shares on the ChiNext market of the Shenzhen Stock Exchange in January 2025 under the stock code 301602. Following the listing, the company expanded its global corporate structure by establishing overseas subsidiaries, including Chaoyan Technology (Hong Kong) Co., Limited in 2025, to strengthen international sales channels and technical collaborations. Furthermore, the company has participated in industrial investment funds to accelerate research and development in high-end ultrasound transducers, automated inspection robotics, and advanced digital radiography technologies.